These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2031258)

  • 41. Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study Group.
    Pescovitz MD; Barone G; Choc MG; Hricik DE; Hwang DS; Jin JH; Klein JB; Marsh CL; Min DI; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL
    Transplantation; 1997 Mar; 63(5):778-80. PubMed ID: 9075853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of significant interaction of fluconazole with cyclosporin.
    Krüger HU; Schuler U; Zimmermann R; Ehninger G
    J Antimicrob Chemother; 1989 Nov; 24(5):781-6. PubMed ID: 2557319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation.
    Mueller EA; Kovarik JM; van Bree JB; Lison AE; Kutz K
    Transplantation; 1994 Apr; 57(8):1178-82. PubMed ID: 8178343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders.
    Gupta AK; Rocher LL; Schmaltz SP; Goldfarb MT; Brown MD; Ellis CN; Voorhees JJ
    Arch Intern Med; 1991 Feb; 151(2):356-62. PubMed ID: 1992963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation.
    Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
    Transplantation; 1996 Jun; 61(12):1699-704. PubMed ID: 8685946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantation.
    Schroeder TJ; Myre SA; Melvin DB; Van der Bel-Kahn J; Stephens GW; Collins JA; Wolf RK; Brown LL; Pesce AJ; First MR
    J Heart Transplant; 1989; 8(1):5-10. PubMed ID: 2647932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients.
    Schroeder TJ; Melvin DB; Clardy CW; Wadhwa NK; Myre SA; Reising JM; Wolf RK; Collins JA; Pesce AJ; First MR
    J Heart Transplant; 1987; 6(2):84-9. PubMed ID: 3305834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients.
    Florea NR; Capitano B; Nightingale CH; Hull D; Leitz GJ; Nicolau DP
    Transplant Proc; 2003 Dec; 35(8):2873-7. PubMed ID: 14697925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of everolimus on steady-state pharmacokinetics of cyclosporine in maintenance renal transplant patients.
    Budde K; Lehne G; Winkler M; Renders L; Lison A; Fritsche L; Soulillou JP; Fauchald P; Neumayer HH; Dantal J;
    J Clin Pharmacol; 2005 Jul; 45(7):781-91. PubMed ID: 15951468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluconazole decreases cyclosporine dosage in renal transplanted dogs.
    Katayama M; Igarashi H; Fukai K; Tani K; Momota Y; Kamishina H; Tagawa M
    Res Vet Sci; 2010 Aug; 89(1):124-5. PubMed ID: 20137796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.
    Klintmalm G; Säwe J; Ringdén O; von Bahr C; Magnusson A
    Transplantation; 1985 Feb; 39(2):132-7. PubMed ID: 3881851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of food on cyclosporine absorption.
    Ptachcinski RJ; Venkataramanan R; Rosenthal JT; Burckart GJ; Taylor RJ; Hakala TR
    Transplantation; 1985 Aug; 40(2):174-6. PubMed ID: 3895624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
    Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
    Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single daily dose administration of cyclosporine in renal transplant recipients.
    Halim MA; Said T; Al-Otaibi T; Eleawa S; Al-Maged H; Gawish AE; Nair P; Al-Muzairai I; Nampoory MR; Al-Mousawi M
    Transplant Proc; 2007 May; 39(4):1225-7. PubMed ID: 17524939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
    Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-Drug Interaction between Tacrolimus and Fluconazole in a Kidney Transplant Recipient.
    Ferchichi K; Ben Hammamia S; Ben Sassi M; El Jebari H; Charfi R; Daghfous R; Gaies E; Trabelsi S
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):356-357. PubMed ID: 38385427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
    Sagedal S; Asberg A; Hartmann A; Bergan S; Berg KJ
    Clin Transplant; 1998 Dec; 12(6):553-6. PubMed ID: 9850449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.